Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself

Carregando...
Imagem de Miniatura
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER MASSON
Autores
PORTO-FERREIRA, Francisco Augusto
TEIXEIRA, Maria Cristina Dias
Citação
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, v.38, n.1, p.40-45, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Health-related quality of life (HRQOL) is impaired in chronic viral hepatitis and a direct role of the virus, although suggested, has not been demonstrated. Our aim was to evaluate HRQOL at blood donation before knowledge of the diagnosis of both hepatitis C virus (HCV) and hepatitis B virus (HBV) so as to elucidate this matter. Methods: Prospectively, 67 sequential patients, 35 with HCV and 32 with HBV, and 67 matched controls were administered the generic Short Form-36 (SF-36) questionnaire. After knowledge of diagnosis, the SF-36 was repeated and a disease-specific questionnaire (Liver Disease Quality of Life, LDQOL-1.0) was also administered. The Wilcoxon test and Mann-Whitney U were used for between-group comparisons. Results: Before knowledge of diagnosis, patients with HCV had worse HRQOL than controls, with statistically significant changes in 7/8 domains of the SF-36, and also in its physical and mental components. In the HBV group, only 2/8 domains and the physical component were significantly different from controls. After diagnosis, similar changes persisted in the HCV group, whereas two more domains were compromised in the HBV group. Comparisons between the HCV and HBV groups did not show significant differences. Conclusion: The finding of greater HRQOL impairment in the HCV group before diagnosis confirms the theory that the presence of HCV in the early stage of the disease is associated with worse quality of life.
Palavras-chave
Referências
  1. Batista-Neves S, 2009, BRAZ J INFECT DIS, V13, P40, DOI 10.1590/S1413-86702009000100009
  2. Bezemer G, BMC GASTROENTEROL, V12, P11
  3. Bondini S, 2007, LIVER INT, V27, P1119, DOI 10.1111/j.1478-3231.2007.01558.x
  4. Bonkovsky HL, 2007, J HEPATOL, V46, P420, DOI 10.1016/j.jhep.2006.10.009
  5. Chen Tian-Hui, 2005, J Zhejiang Univ Sci B, V6, P936, DOI 10.1631/jzus.2005.B0936
  6. Daruich Jorge, 2007, Acta Gastroenterol Latinoam, V37, P168
  7. Dias Teixeira MC, 2005, ANN HEPATOL, V4, P264
  8. Forton DM, 2003, J VIRAL HEPATITIS, V10, P81, DOI 10.1046/j.1365-2893.2003.00416.x
  9. Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688
  10. Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132
  11. Gotardo DRM, 2008, LIVER INT, V28, P99, DOI 10.1111/j.1478-3231.2007.01606.x
  12. Gralnek IM, 2000, AM J GASTROENTEROL, V95, P3552
  13. Helbling B, 2008, GUT, V57, P1597, DOI 10.1136/gut.2007.142844
  14. John-Baptiste AA, 2009, AM J GASTROENTEROL, V104, P2439, DOI 10.1038/ajg.2009.346
  15. Kim JH, CLIN GASTROENTEROL H, V10, P291
  16. Koff RS, 1999, HEPATOLOGY, V29, P277, DOI 10.1002/hep.510290127
  17. Lam ETP, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-52
  18. Lowry D, J VIRAL HEPAT, V17, P352
  19. Marcellin P, 2008, LIVER INT, V28, P477, DOI 10.1111/j.1478-3231.2008.01696.x
  20. MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006
  21. Mendez-Sanchez N., ANN HEPATOL S, V9, P7
  22. Minuk GY, 2005, J VIRAL HEPATITIS, V12, P51, DOI 10.1111/j.1365-2893.2005.00553.x
  23. Niederau C, 2008, Z GASTROENTEROL, V46, P22, DOI 10.1055/s-2007-963534
  24. Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138
  25. Paradis V, HEPATOLOGY, V56, P532
  26. PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018
  27. Quarantini LC, 2008, J MED VIROL, V80, P419, DOI 10.1002/jmv.21094
  28. Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504
  29. Salles Nanci A, 2003, Rev Panam Salud Publica, V13, P111, DOI 10.1590/S1020-49892003000200011
  30. Schwarzinger M, 2004, HEPATOLOGY, V40, P1434, DOI 10.1002/hep.20468
  31. Slavenburg S, 2008, LIVER INT, V28, P286
  32. Slavenburg S, 2008, LIVER INT, V28, P285, DOI 10.1111/j.1478-3231.2007.01622.x
  33. Strauss E, 2006, LIVER INT, V26, P755, DOI 10.1111/j.1478-3231.2006.01331.x
  34. Taliani G, 2007, J VIRAL HEPATITIS, V14, P875, DOI 10.1111/j.1365-2893.2007.00883.x
  35. Teixeira MC, 2004, GED, V23, P5
  36. Teixeira MCD, 2006, TRANSFUSION, V46, P278, DOI 10.1111/j.1537-2995.2006.00712.x
  37. Teuber G, 2008, J HEPATOL, V49, P923, DOI 10.1016/j.jhep.2008.07.025
  38. Weissenborn K, 2006, GUT, V55, P1624, DOI 10.1136/gut.2005.080267
  39. Woo G, CAN J GASTROENTEROL, V26, P445
  40. Wu Gui-cheng, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P275
  41. Younossi Z, 2007, HEPATOLOGY, V45, P806, DOI 10.1002/hep.21565
  42. Zautra A, 1979, COMMUN HLTH REV, V4, P3